Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: No.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Diffusion Weighted MRI Characterization of White Matter Injury Produced by Axon-sparing Demyelination and Severe Contusion Spinal Cord Injury in Rats.
Disruption of estrous cycle homeostasis in mice with experimental autoimmune encephalomyelitis.
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Nerve pathologic features differentiate POEMS syndrome from CIDP.
The topographical model of multiple sclerosis: A dynamic visualization of disease course.
Online CBT in patients with multiple sclerosis and depression.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Environmental factors and their interactions with risk genotypes in MS susceptibility.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Lotensin: Cheap 180
Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Pages
« first
‹ previous
…
719
720
721
722
723
724
725
726
727
…
next ›
last »